A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...
Financial and security chaos at the once-pioneering genetic testing firm has intensified concerns about user data. Here's how ...
Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...
A huge data breach followed by a plummeting valuation has stoked fears of a sale of 23andMe along with all of its customers' genetic data.
Gray’s optimism on IPO markets provided a positive gloss to its muted asset sales in third-quarter results released on Thursday. The biggest story at Blackstone is its continued growth in almost any ...
Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world.
Why it matters: 23andMe, the popular genetic testing company, is in financial turmoil and considering privatization. This ...
Me Holding Co. (NASDAQ: ME) has announced a 1-for-20 reverse stock split of the company's class A and class B common stock, ...
In what now seems like an act of reckless naivety, I bought my brother a 23andMe at-home DNA-test birthday present. Now the struggling company may sell its treasure trove of genetic data.
SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced ...
Americans curious about their ancestry likely paid for a DNA test through 23andMe. But with their future unclear, what will ...
SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), announced today the completion of the previously announced 1-for-20 reverse stock sp ...